Global Biobetters Market
Global Biobetters Market Analysis to 2034 by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region, Featuring Exhaustive Profiles of the Top 10+ Players
09. April 2024 11:54 ET | Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region" report has been...
Global Biosimilars Market
Global Biosimilars Market Size, Share & Trends Analysis 2023 - 2030: Unlocking Affordable Therapies - The Increasing Role of Biosimilars in Patient Care
16. August 2023 09:13 ET | Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By...
BiondVax LOGO.png
BiondVax CEO Issues Letter to Shareholders
30. Dezember 2022 07:30 ET | BiondVax Pharmaceuticals Ltd.
JERUSALEM, Dec. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...
22157.jpg
Insights on the Biosimilars Global Market to 2025 - Featuring Amgen, Cipla and Pfizer Among Others
15. Juni 2021 06:18 ET | Research and Markets
Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market should reach $60.1...